Filter Search


Healthcare-and-Medical


Location Summary Deadline
Germany Tenders Are Invited For Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Tezepelumab, Atc R03dx11 For The Time 01.06.2023 - 31.2022025.completion Of A Non -exclusive Discount Agreement Accordin 2025-08-13
Germany Tenders Are Invited For Canceling Of The Open House Process Pharmaceutical Discount Contracts Rivaroxaban, Effectiveness 2.5 Mg (b01af01).canceling Of The Open House Process Pharmaceutical Discount Contracts Rivaroxaban, Effectiveness 2.5 Mg (b01af01) 2025-08-13
Germany Tenders Are Invited For Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Benralizumab, Atc R03dx10 For The Time 01.06.2023 - 31.2012025.completion Of A Non -exclusive Discount Agreement Accordi 2025-08-13
Germany Tenders Are Invited For Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Alirocumab, Atc C10ax14 For The Period 01.06.2023 - 31.2012025.completion Of A Non -exclusive Discount Agreement Accordi 2025-08-13
Germany Tenders Are Invited For Cancellation Of The Open House Procedure Pharmaceutical Discount Contracts Ambrisentan (c02kx02).cancellation Of The Open House Procedure Pharmaceutical Discount Contracts Ambrisentan (c02kx02) 2025-08-13
Germany Tenders Are Invited For Cancellation Of The Open House Procedure Pharmaceutical Discount Contracts Perindopril And Indapamide (c09ba54).cancellation Of The Open House Procedure Pharmaceutical Discount Contracts Perindopril And Indapamide (c09ba54) 2025-08-13
Germany Tenders Are Invited For Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Latanoprost (excl. Daring Forms As Individual Doses), Atc S01e01 For The Time 01.06.2023 - 31.20225.completion Of A Non 2025-08-13
Germany Tenders Are Invited For Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Latanoprost + Timolol (excl. Daring Forms As Individual Doses), Atc S01ed61 F.z. 01.06.23 - 31.05.25.completion Of A Non- 2025-08-13
India Annual Tender _2024-25_supply And Delivery Of Public Health Material At Pannaipuram Town Panchayat, Dist 2025-08-14
India Supply Of Capd Fluid 2.5% Dextrose 2 Litre Bottle With Minicap. 2025-08-14
Whats app